Skip to content
AGI Future Foundation PBC

Investor Relations — Information Only · Series Raises

Later series raises: one series, one raise, one cap table

After SmartCiti.X, the studio's other series would raise one at a time — each for its own project, each with its own documents, its own cap table, and its own bank account. The suggested range for each is $100,000 to $500,000. No series raise is open, no series has been designated with a seated council and a segregated account in the files reviewed, and no money has been raised for any series. This page explains how a series raise would work, what it could and could not do, and what must exist first.

Express interestRead the structure

$100k–$500ksuggested per series
33named W3 sub-series
1series at a time

What a series is — and what it is not

W3 LLC is intended as a Wyoming series LLC. It is not a single company that raises one round for all its series. Each series is a separate cell with separate assets, liabilities, books, and bank account, if separateness is maintained. A "W3 raise" therefore means one of two different things, and they must not be confused: a raise by one series, for that series' project; or a raise by the master LLC or AGI Corp as manager, for studio or management purposes. Those are different efforts, with different issuers, different documents, and different disclosures. No single effort may promise anyone a share of all 33 series unless counsel structures a fund or master effort expressly for that purpose, with its own formal documents.

The list of series itself must be described accurately. The April 2026 internal printout names 33 sub-series, Series 1 through 33, contiguous. That printout is not a Wyoming Secretary of State filing, not a designation, and not evidence of a bank account, EIN, intellectual property, or council for any series. The safe way to describe it, from the corporate evidence file, is "33 named W3 sub-series in the April 2026 internal list". Site copy that has said "33 DAO subsidiaries", "35 cells", or "AGI Corp plus 30 more" is not a capitalization table and not a description of a raise. Until series are designated, there is no series to take part in. Biota, one of the anchored worlds, does not appear in the series list, and no series number may be assigned to it by assumption. The Delaware cohort series — C1S1, C1S2, and C1S3, for Cohort 1, Series 1 through 3 — are labels in a register, not yet legal names of formed entities, and each would need the Delaware master filed and the series designated before any raise.

One series, one raise — money never pools across series by defaultSeries A — one projectOwn documents · own cap tableOwn bank account · own CouncilSeries B — one projectOwn documents · own cap tableOwn bank account · own CouncilSeries C — one projectOwn documents · own cap tableOwn bank account · own CouncilSeries A money is not Series B money, and neither is master LLC money —unless a signed agreement and counsel's advice expressly permit a specific transfer, minuted, priced, and reported.

The series pages on this site describe the worlds and projects — Cognition.X, Empathic.X, Diagnostic.X, Robotics DAO, InfoGurus, and the rest — as project descriptions. A project description is not a company, not a designation, and not a raise. The series index is the place to read what each project is intended to be; this page is the place to understand what a raise for one of them would require.

Suggested ranges — planning only

The suggested range for each other W3 series is $100,000 to $500,000 for a first series, and the same $100,000 to $500,000 range is suggested for each Delaware cohort series, C1S1, C1S2, and C1S3, for a first round, if Gate 1 has been passed. These are suggested ranges only — not prices, not terms, not appraisals, and not promises. Each series' valuation is set per series at its own round; the suggested figures for other entities must not be copied to a series. The Foundation's suggested $50,000,000 figure applies only to a for-profit benefit corporation track, SmartCiti.X's suggested $25,000,000 figure applies only to the SmartCiti.X corporation, and AGI Corp's suggested $20,000,000 figure applies only to the studio. None of those figures belongs on a series page, and the suggested ranges for different series must never be added together into a single family total. Each raise has a different issuer, different documents, different eligibility, and different risks, and a summed figure would hide all of that.

The $100,000 to $500,000 range is the planning range for a pre-product series in the corporate advice. SmartCiti.X is positioned differently — as a product and sites series with a larger suggested round — which is why its figures are larger. A series that reaches its first raise with a signed pilot customer, a built prototype, and a seated council would be priced by its own diligence at the time, and may be valued materially lower than any planning figure, or declined at any price. The range is a starting point for planning, not a commitment to any number.

What each series could raise — once designated and formed

Equity, for that series

A priced round for that series, with a charter or operating agreement amendment, formal purchase documents, an investor questionnaire, and a cap table for that series alone. The equity is in that series, not in the family, not in the Foundation, and not in any other series.

SAFE or convertible note

A post-money SAFE or convertible note for that series, or for AGI Corp as studio — counsel chooses one issuer per round. Board or manager and Steward Council authorization is required, with cap, discount, and round size set, for accredited investors, under Regulation D, with a Form D filing.

Revenue and customer contracts

The cleanest first raise for many series: a customer pays for a product or service, not for securities. No securities sale is needed for a genuine customer contract, as counsel confirms it is not, in substance, an investment contract. Customers come first.

Grants — only where eligible

A grant is possible only if the series' purpose and the grantor's eligibility rules allow it. A for-profit series is generally not eligible for charitable grants; a series that is, in substance, a charitable program should be run through the Foundation, not through a for-profit series, with a grant agreement.

AGI Corp as investor or manager

AGI Corp may invest in, or manage, a series under a written agreement — a management fee or ownership interest as stated in that series' appendix. That agreement must be approved by the series' Steward Council and AGI Corp's board, with recusals for interested directors.

What a series cannot raise on

A series cannot raise on the Foundation's or the Fellowship's nonprofit status, tax-exempt status, or charitable reputation. No "church-backed" or "nonprofit-backed" investment language may be used without counsel's exact wording approval.

What a series cannot do

The limits are as important as the possibilities. A series cannot pool funds across series: Series C1S1 money is not Series C1S2 money, and neither is W3 master money, unless a signed agreement and counsel's advice expressly permit a specific transfer, and then it is minuted, priced, and reported. A series cannot issue a SAFE, token, or profit interest in the name "W3", "C1S1" alone, or a project nickname. The issuer must be the legal series name — the master LLC name followed by the series designation — or AGI Corp, if AGI Corp is the issuer for that round. A series cannot promise Open Global Investment participation, Windfall Clause shares, or a share of the family's profits, because those programs have no published terms; a formal document that promises them without signed terms is a misrepresentation risk. A series cannot offer securities by general solicitation — public posts, public links, or site buttons inviting investment — unless counsel has expressly chosen Regulation D Rule 506(c) and verification is in place. The Foundation site's investment language must not be used as a series sales page.

A series also cannot sell what the nonprofits cannot sell. It cannot raise on the Foundation's nonprofit status, and it cannot use Fellowship donations to fund a series, except on counsel's written advice that a specific transfer serves a religious purpose at fair value — the default is no. Fellowship donations never fund a series' manufacturing or site purchases by default. Foundation donations and grants may fund a studio project only as a grant serving a charitable purpose, with reporting, under the structure documents, approved by disinterested Foundation directors. Foundation money is not series equity, not a SAFE, and not a subsidy for a commercial series' losses, unless counsel advises a specific lawful structure in writing.

What must exist before any series raise opens

The corporate advice lists the documents and steps that must exist before any series raise opens, and every item matters. The master LLC must be filed and its operating agreement signed — the Wyoming W3 operating agreement for W3 series, and the Delaware operating agreement for the cohort series. That series must be designated in the operating agreement appendix, with its purpose, its manager, its Steward Council of three consenting humans, and segregated books and a segregated account. The series must have a cap table and an intellectual property chain showing who owns the series' intellectual property by signed assignment or license. The series must have a budget and a use of proceeds stated as actuals, not as projections presented as history. Securities counsel must prepare the formal documents for that series: disclosure documents with risk factors, capitalization including all SAFEs and options, related-party transactions with the Foundation, the Fellowship, AGI Corp, and other series, and use of proceeds; the SAFE or purchase documents; and an investor questionnaire with accredited verification. The board or manager and the Steward Council must authorize the round with cap, discount, and round size for a SAFE, or price and valuation for a priced round — all numbers filled in, not "standard terms". A Form D filing and a state notice calendar must be in place, with Form D filed within fifteen days of the first sale. And a bank account must exist for that series, in that series' legal name, with the series manager and Council-approved signers. None of those items is evidenced as complete for any series in the files reviewed.

Who a series would approach first — and in what order

Customers first: a paying customer validates a series better than any deck, and does not dilute anyone. Next, angel and pre-seed investors who understand series LLCs and agent-managed ventures, and who are accredited — with a series-specific deck covering that series' product, team, intellectual property, budget, and risks, not a family-wide deck that mixes nonprofit, church, and commercial claims. Then studio-adjacent investors: AGI Corp itself, as manager or investor under a written agreement, and, where counsel permits, other series — with every cross-series investment disclosed to all affected investors. Donors must not be approached for a series; they belong on the Foundation or Fellowship donation tracks. Grantors expecting a nonprofit must not be approached for a for-profit series; they belong with the Foundation, if eligible. And the general public must not be approached through the Foundation site's investment section.

The sequencing across the family is: clean up first, then Foundation and Fellowship donation rounds, then AGI Corp incorporation and SAFE authorization, then the first series designation and first series raise — one series, one set of documents, one cap table — to prove the series model with one clean closing before a second series round opens. Subsequent series raises follow one at a time, each with its own formal documents, cap table, and account. Three series rounds must never be opened on one deck. Open Global Investment and the Windfall Clause come only after counsel drafts signed terms for them, as a separate, expressly disclosed program — never as a promise inside an earlier SAFE or equity document. The full sequence is on the process page.

The series themselves — a brief orientation

The 33 named sub-series on the April 2026 internal list span diagnostics, robotics, cognition, genomics, blockchain, and other domains; the series index on this site describes each project. Two deserve a note here because readers ask about them. Robotics DAO, Series 30, is the background manufacturing-partner series for SmartCiti.X; it is not the SmartCiti.X corporation, not a co-issuer of the $10,000,000, and not a double raise. InfoGurus, Series 33, is the last series on the list. SmartCiti.X, Series 10 on that list, is no longer the SmartCiti.X raise issuer — the new corporation is, as described on the SmartCiti.X page. No series on the list has a valuation, a round size, a customer, or a signed agreement evidenced in the files reviewed, and none should be described as if it did. A series that has not passed Gate 1 — customer and problem research from human interviews, feasibility drafts, a financial model draft, designation, a signed charter, and a named council — cannot pass to Build as an operating company, and cannot take investment.

What is still missing

Stated plainly: the W3 master LLC filing is not evidenced; the Delaware master filing is not evidenced; no series designation, council, segregated account, cap table, intellectual property chain, or formal document set is evidenced for any series; no Windfall or Open Global Investment terms exist; and no series raise is open. The $100,000 to $500,000 ranges are suggested planning figures only. Anyone considering a future series should expect the formal documents, when they exist, to carry the actual terms, risks, and disclosures for that series alone — and should expect to be asked for accredited-investor verification before any discussion of terms. The studio that would build these series is described on the studio page.

Express interestRead the structure

Sources for this page: corporate paperwork files 13 (Cohort Series Register and Intake), 16 (Venture Studio Operating Model), 17 (Stage Gates and Portfolio Dashboard), 27 (Corporate Raise Advice), 30 (W3 LLC Series Evidence), 32 (Suggested Valuations and Raises), 46 (SmartCiti.X as New Corporation), and 52 (Truth Audit). Nothing on this page is legal, tax, or financial advice. Contact: [email protected].